Pforte Helmholtz Munich Banner

We are Helmholtz Munich.

We discover breakthrough solutions for better health in a rapidly changing world.

We discover breakthrough solutions for better health in a rapidly changing world.

Our Vision & Mission

Our world is constantly changing. This impacts our health. Many widespread diseases such as diabetes, allergies and lung diseases are on the rise. Climate change is causing new diseases to emerge.

We develop solutions for a healthier future. Our cutting-edge research is the springboard for medical innovations. Together with our partners, we accelerate the transfer from ideas to applications, from labs to startups, from science to society.

Our Management

Martin Hrabe de Angelis
Prof. Dr. Dr. h.c. mult. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting)

View profile
Michael Frieser
Dr. Michael Frieser

Administrative Managing Director

View profile
2555
Employees
90
Nations
1371
Publications in 2024
422
PhD students
31
Spin-Offs
66
ERC Grants

Member of the Helmholtz Association

  • We belong to the largest research network in Germany.
  • We receive long-term core funding for our research projects.
  • We offer our scientists an excellent infrastructure.

Our Locations

How We Work

Awards & Grants

See all
Prof. Ulrike Protzer erhält Bundesverdienstkreuz

Awards & Grants, Molecular Targets and Therapeutics, VIRO,

Ulrike Protzer Receives the Federal Cross of Merit

On October 28, 2025, Prof. Dr. med. Ulrike Protzer was awarded the Bundesverdienstkreuz (Federal Cross of Merit). This honor recognizes her outstanding contributions to the field of virology – particularly her pioneering translational research…

20251022_HHDC Cure Gala_092

Awards & Grants, Diabetes, IDF,

Anette-Gabriele Ziegler Receives Hamm International Prize for Diabetes Research

Prof. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research, is awarded with this year’s Hamm International Prize. She is being honored for her research to understand the pathogenesis of type 1 diabetes and efforts…

German Medical Award 2025 for Prof. Ulrike Protzer

Awards & Grants, Molecular Targets and Therapeutics, VIRO,

Ulrike Protzer Receives the German Medical Award 2025

Prof. Ulrike Protzer, Director of the Institute of Virology at Helmholtz Munich and Chair for Virology at the Technical University of Munich, has been awarded the German Medical Award 2025 in the category "Female Doctor of the Year". The honor…

Man standing on ridge reflected in the lake.

Awards & Grants, Pioneer Campus,

Supporting Creative Science: Janna Nawroth Awarded VW Night Science Grant

Dr. Janna Nawroth, Principal Investigator at the Helmholtz Pioneer Campus at Helmholtz Munich, has been awarded a grant from the VolkswagenStiftung’s Night Science Initiative, a program designed to foster creativity as a driver of scientific…

Zeynep Akata receives 2025 ZukunftsWissen Award

AI, Awards & Grants, Computational Health, EML,

Zeynep Akata Receives 2025 ZukunftsWissen Award

Professor Zeynep Akata has been awarded the 2025 ZukunftsWissen Prize by the German National Academy of Sciences Leopoldina and the Commerzbank Foundation in recognition of her outstanding scientific contributions. The €50,000 award was presented on…

Abstract blue tech background with DNA strands

AI, Awards & Grants, Computational Health, Health AI,

Niki Kilbertus Receives ERC Starting Grant for Causal Analysis in Complex Systems

Prof. Niki Kilbertus, Helmholtz AI group leader at Helmholtz Munich and professor at the Technical University of Munich, has received an ERC Starting Grant for the project DYNAMICAUS, which focuses on advancing the understanding of cause-and-effect…

kind-spielt-institut-fotoshooting-nozy-andreas pfohl-220727_0587 mit Logofr1da

Awards & Grants, Diabetes, IDF,

Fr1da-Cohort-Study Receives Grant to Facilitate the Integration of Early-Stage Type 1 Diabetes Screening Into Standard Care

The Helmholtz Munich Institute for Diabetes Research has been awarded a grant of over 1 Mio. Dollar from Breakthrough T1D, a global organization focused on type 1 diabetes research and advocacy, to intensify the longstanding Fr1da-Cohort-Study. The…

Ozempic pens and measurement tape.

Awards & Grants, Diabetes, HI-MAG, IPI, IDM,

CarePath: Helmholtz Munich Joins EU Project to Support People With Chronic Conditions

A new European research initiative, CarePath, has launched with the goal of helping people with long-term health conditions manage their treatment more effectively and comfortably. By offering personalized tools and support, the project aims to…

A vibrant abstract composition shows interconnected blue dots and lines in a dark environment

Awards & Grants, Computational Health, ICB, Bioengineering, IBMI, Molecular Targets and Therapeutics, MCD,

Three ERC Proof of Concept Grants for Helmholtz Munich

Researchers at Helmholtz Munich have secured three prestigious Proof of Concept Grants from the European Research Council (ERC). This funding will enable them to advance innovative projects across diverse areas of biomedical research. With a total of…

2025 Future Insight Prize Awarded to Magdalena Götz for Breakthroughs in Brain Regeneration

Awards & Grants, Stem Cells, ISF,

2025 Future Insight Prize Awarded to Magdalena Götz for Breakthroughs in Brain Regeneration

Merck, a leading science and technology company, awarded the 2025 Future Insight Prize to Prof. Magdalena Götz from Helmholtz Munich. The award – a € 250,000 research grant – recognizes Götz’s pioneering work in the field of regenerative…

Matthias Tschöp_122

Awards & Grants,

Matthias Tschöp Awarded Lichtenberg Medal 2025 by Göttingen Academy of Sciences and Humanities

Alexander-von-Humboldt Professor Matthias Tschöp was awarded the esteemed Lichtenberg medal on July 4, 2025, in recognition of his groundbreaking discoveries in the field of medicine. The award, which represents the highest honor of the Göttingen…

m4_Award_Ceremony_press

AI, Awards & Grants, Stem Cells, IDG, Computational Health, ICB,

m4 Award 2025 Goes to Helmholtz Munich for RNA Therapy Innovation

Researchers at Helmholtz Munich received the pre-seed competition m4 Award 2025 for their project SYNTRA, which develops new methods to deliver RNA-based medicines using artificial intelligence (AI). The award supports innovative medical research in…

HELENA Award Ceremony July 2

Events, Awards & Grants, Stem Cells, ISF, Environmental Health, LHI, Pioneer Campus,

Honoring Doctoral Researchers and Supervisors at Helmholtz Munich

Outstanding achievements in early-career research and academic mentoring were celebrated at an award ceremony held on July 2 at Helmholtz Munich. Two Doctoral Researcher Awards and the Best Supervisor Award were presented – prestigious honors that…

Leipziger Wissenschaftspreis 2025 für Antje Körner

Awards & Grants, Diabetes, HI-MAG,

Leipzig Science Award 2025 for Antje Körner

Professor Antje Körner has been awarded the Leipzig Science Award 2025. The prize, endowed with €10,000, recognizes her research in the field of childhood obesity and metabolic diseases. The award ceremony took place during a formal event at Leipzig…

Prof. Carsten Schmidt-Weber_Banner

Awards & Grants, Environmental Health, IAF,

EAACI Fellow Award for Carsten Schmidt-Weber

Carsten Schmidt-Weber, Director of the Institute of Allergy Research at Helmholtz Munich, has been honored with the EAACI Clinical Fellow Award 2025. The prestigious European Academy of Allergy and Clinical Immunology (EAACI) presented him with the…

Our Organization

How is Helmholtz Munich funded?

Helmholtz Munich is a research institution owned by the Federal Government of Germany and the Free State of Bavaria which finance the center in a ratio of 90:10. In 2020, the funding amounted to 271.5 million euros. Addiotional third-party funding resulted in a total budget of 331,6 million euros in 2020.

How does Helmholtz Munich develop its research goals?

The centers of the Helmholtz Association are divided into six research fields:

  • Health
  • Energy
  • Earth and Environment
  • Aeronautics, Space and Transport
  • Information
  • Matter

For each research area, scientists develop research programs that are evaluated by international experts. This evaluation forms the basis for the program-oriented funding of Helmholtz research. Helmholtz Munich is fully anchored in the research field Health. For the current period our research is orientated towards the five topics of the program-oriented funding "Environmental and Metabolic Health" (ENABLE). This program provides the strategic research framework for Helmholtz Munich for the next seven years.

Helmholtz Munich is also part of Helmholtz Health. Together with five other Helmholtz Health Centers, we develop solutions for a healthier society in a network of cutting-edge biomedical research that is unique in Europe. Our mission is to translate research results as quickly as possible into advances for our society, our healthcare system and the economy. In order to continuously expand the transfer portfolio, to further increase the speed of transfer and to make essential contributions more effectively, Helmholtz Health is jointly pursuing a seven-point charter across the centers.

Supervisory Board

The Supervisory Board monitors the legality, expediency and economic efficiency of the work of the Board of Directors. It decides on the general research objectives, important research policy and financial matters, and the principles for performance review. The Supervisory Board currently has eight members. Of these, the shareholders (Federal Republic of Germany represented by the Federal Ministry of Education and Research, Free State of Bavaria represented by the Bavarian State Ministry of Finance and Home Affairs) delegate five members. In addition, there are three further members from the Saxon State Ministry of Science, Culture and Tourism and representatives of science and business.

Chairwoman: MinDir'in Prof. Dr. Veronika von Messling

Board of Directors

The Board of Directors acts in accordance with the law, the Articles of Association, the Rules of Procedure and the instructions of the Shareholders' Meeting and the Supervisory Board. It shall cooperate with the other bodies of the Center.  

Member and Spokesperson of the Executive Board (acting): Prof. Dr. Dr. h.c. mult. Martin Hrabě de Angelis
Administrative Managing Director: Dr. Michael Frieser

Management Committee

The Management Committee advises the Board of Directors and makes recommendations on upcoming decisions on important matters, those of a fundamental nature and those of significant financial importance. Members of the Management Committee are scientific and administrative executives.

Chairman: Prof. Dr. Dr. h.c. mult. Martin Hrabě De Angelis 

Scientific Advisory Board

The Scientific Advisory Board advises the Supervisory Board and the Board of Directors. It is also responsible for evaluating the work of Helmholtz Munich. At present, eleven external scientists belong to the scientific advisory board.

Chairman: Prof. W. Langhans

Works Council

The works council is the elected representative body of the Helmholtz Munich employees and represents their interests vis-à-vis the Board of Directors.

Contact: betriebsratspam prevention@helmholtz-munich.de

Organization Chart

Please find our Organization Chart here.

Building a better world?

Join our team.